CASI PHARMACEUTICALS INC's ticker is CASI and the CUSIP is 14757U109. A total of 60 filers reported holding CASI PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $8,222,000 | +1.3% | 10,150,000 | 0.0% | 0.02% | +26.7% |
| Q4 2021 | $8,120,000 | -32.8% | 10,150,000 | 0.0% | 0.02% | -34.8% |
| Q3 2021 | $12,079,000 | -23.2% | 10,150,000 | 0.0% | 0.02% | -20.7% |
| Q2 2021 | $15,733,000 | -35.4% | 10,150,000 | 0.0% | 0.03% | -38.3% |
| Q1 2021 | $24,360,000 | +18.0% | 10,150,000 | +45.0% | 0.05% | +11.9% |
| Q4 2020 | $20,650,000 | +95.6% | 7,000,000 | +1.4% | 0.04% | +68.0% |
| Q3 2020 | $10,557,000 | – | 6,900,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| IDG-Accel China Growth Fund III Associates L.P. | 7,973,536 | $23,522,000 | 27.18% |
| Consonance Capital Management LP | 7,576,431 | $22,350,000 | 2.09% |
| Wellington Shields & Co., LLC | 1,812,769 | $5,348,000 | 1.92% |
| Wellington Shields Capital Management, LLC | 2,071,765 | $6,112,000 | 0.82% |
| Ikarian Capital, LLC | 1,268,154 | $3,741,000 | 0.16% |
| Sio Capital Management, LLC | 203,432 | $600,000 | 0.12% |
| Zebra Capital Management LLC | 11,182 | $33,000 | 0.04% |
| FEDERATED HERMES, INC. | 7,000,000 | $20,650,000 | 0.04% |
| GSA CAPITAL PARTNERS LLP | 52,146 | $154,000 | 0.02% |
| BOOTHBAY FUND MANAGEMENT, LLC | 161,949 | $478,000 | 0.02% |